Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

BioRestorative Therapies (BRTX) Return on Equity (2016 - 2025)

BioRestorative Therapies (BRTX) has disclosed Return on Equity for 15 consecutive years, with 4.12% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Equity fell 295.0% year-over-year to 4.12%, compared with a TTM value of 4.12% through Sep 2025, down 295.0%, and an annual FY2024 reading of 1.25%, up 25.0% over the prior year.
  • Return on Equity was 4.12% for Q3 2025 at BioRestorative Therapies, down from 2.38% in the prior quarter.
  • Across five years, Return on Equity topped out at 8.45% in Q1 2021 and bottomed at 8.91% in Q4 2021.
  • Average Return on Equity over 5 years is 1.02%, with a median of 1.67% recorded in 2022.
  • The sharpest move saw Return on Equity soared 799bps in 2021, then tumbled -1039bps in 2022.
  • Year by year, Return on Equity stood at 8.91% in 2021, then surged by 79bps to 1.89% in 2022, then grew by 23bps to 1.47% in 2023, then increased by 15bps to 1.25% in 2024, then plummeted by -230bps to 4.12% in 2025.
  • Business Quant data shows Return on Equity for BRTX at 4.12% in Q3 2025, 2.38% in Q2 2025, and 1.67% in Q1 2025.